InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,228.83
(
0.12%
)
US TECH 100
17,712.00
(
0.17%
)
Dow Jones
39,606.56
(
0.24%
)
Brent Oil
83.37
(
1.19%
)
Bitcoin
62,976.86
(
2.49%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Atlanta1

Send PM Follow Ignore
Followers 195
Posts 31558
Boards Moderated 3
Alias Born 04/08/2002

Atlanta1

Re: Atlanta1 post# 95462

Tuesday, 10/18/2016 7:22:25 AM

Tuesday, October 18, 2016 7:22:25 AM

Post# of 97237
Orphan designation is expected to provide increased communication and guidance from regulators and 10-year market exclusivity should marketing authorization be obtained

- Orphan designation for Iomab-B follows SME (small or medium-sized enterprise) status, which was granted in August 2016

- Iomab-B now has orphan designation in the US and EU

$ATNM
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up